Clinical Trial Diversity | Closing The Gap to Achieve Health Equity

Powered by: Tandem Diabetes Care

DESCRIPTION 

As diversity, equity, inclusion and accessibility increasingly become top priorities for organizations worldwide, the healthcare sector still lags considerably. Racial and ethnic minorities comprise 39% of the U.S. population, yet their rates of inclusion in clinical trials range from 16% to as low as 2%. Please join us for a dynamic discussion of why diversity is essential for medical developments including clinical trials, precision genomics and DNA sequencing. Top experts will share why having medications that are suited to reflect and treat the intended treatment population is how we advance health equity. Expect to learn best practices and principles on improving diversity in research and other vehicles that extend greater health outcomes to underserved communities. We hope you’ll take away actionable steps as a patient and consumer and encourage diverse representation in clinical trials and beyond.

SPEAKERS:

• Stephanie Habif | Vice President | Behavioral Sciences | Tandem Diabetes Care
• Emily Sherman| Clinical Trials Diversity Operations Lead | Pfizer 
• Daniel Perez | CEO | MACRO Trials

Presented by: Athena's Life Sciences Special Interest Group